Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010–2015)
Table 3
Univariate analysis of overall and disease-specific survival (1142 cases included).
Characteristic
value for log rank
Cumulative survival rate at 5 y, %
OS
DSS
OS
DSS
Overall
61.8
66.5
Age rangea
Young
Reference
Reference
71.4
68.9
Mid
0.001
0.798
61.0
72.6
Elder
<0.001
0.01
31.9
59.7
Sex
Female
Reference
Reference
62.9
68.0
Male
0.166
0.379
60.8
65.2
Race
White
Reference
Reference
60.2
65.5
Others
0.042
0.049
84.4
91.1
Origin
Hispanic
Reference
Reference
57.6
66.7
Non-Hispanic
0.212
0.143
61.2
61.4
Laterality
Right
Reference
Reference
60.2
67.9
Left
0.698
0.475
61.7
65.2
AJCC stage
I
Reference
Reference
88.0
93.6
II
<0.001
<0.001
67.4
72.9
III
<0.001
<0.001
46.3
49.5
IV
<0.001
<0.001
13.7b
14.4 b
Summary stage
Localized
Reference
Reference
64.3
69.3
Regional
0.013
0.02
60.1
63.4
Distant
<0.001
<0.001
13.5b
11.2 b
Metastasis at diagnosis
None
Reference
Reference
62.6
67.4
Distant
<0.001
< 0.001
13.5b
11.2 b
Surgery
Performed
Reference
Reference
54.7
59.5
Not performed
<0.001
<0.001
67.3
71.8
Radiation
Performed
Reference
Reference
69.0
74.2
Not performed
<0.001
<0.001
52.6
55.3
Chemotherapy
Performed
Reference
Reference
56.0
56.0
Not performed
0.160
0.059
61.3
66.8
Marital status
Married
Reference
Reference
62.1
66.1
Others
0.824
0.61
61.4
67.1
Abbreviations: OS, overall survival; DSS, disease-specific survival; AJCC, American Joint Committee on Cancer. aAge stratification was different in OS and DSS, according to results of X-tile process. bDue to lack of patient sample, the longest follow-up time was 46 months. We used the latest survival data instead of accurate 5-year accumulative survival rate. Bold letter indicates that measurements are statistically significant compared with references ();;.